Reduction in Number of Botox Injections for Urgency Urinary Incontinence
Part of paid clinical trials in Charlottesville, Virginia.
- Sponsor
- University of Virginia
- Study ID
- NCT04731961
- Status
- Recruiting
Conditions
- Urgency Urinary Incontinence
Eligibility Criteria
- Sex
- FEMALE
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Standard of care (15 Botox injections) — PROCEDUREThe controls will be given the standard of care of 15 Botox injections.
- Experimental Arm (5 Botox injections) — PROCEDURE5 Botox injections will be given, with each injection containing three times the amount of Botox than each of the 15 injections given in the standard of care arm.
Study Details
The overall objective of this study is to determine if a reduced injection site protocol (5 injection sites) using an equivalent amount of Botox provides comparable relief of Urgency Urinary Incontinence (UUI) symptoms compared to the standard injection site protocol (15-20 injection sites). Our central hypothesis is that the 5-site injection protocol is non-inferior in terms of relief of UUI symptoms compared to the standard injection site protocol, measured by a non-inferior reduction in the number of UUI episodes per day.
Key Dates
- Start date
- Feb 23, 2021
- Status verified
- Jan 2025
- Primary completion
- Dec 31, 2025
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 56 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: ControlsSubjects in this arm will be administered the standard injection site protocol (15 sites).
- Experimental: ExperimentalSubjects in this arm will be administered the same amount of Botox in 5 injection sites.
Primary Outcome Measure
Reducton of Urgency Urinary Incontinence episodes in standard of care versus modified treatment group [ Time Frame: 6 months ]
Central Contacts
- Monique Vaughan, MD4349241955
- amanda r urban, MS14344093100
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Virginia | Charlottesville | Virginia | 22903 |
Find similar trials in Charlottesville, VA
By research site
Related Studies
- Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary IncontinencePHASE4 · Recruiting · Women and Infants Hospital of Rhode Island · Birmingham, Alabama